期刊文献+

L-4F改善狼疮样小鼠肾脏病变 被引量:1

L-4F attenuates the injury of lupus nephritis in a lupus mouse model
下载PDF
导出
摘要 目的:探讨载脂蛋白A-I类似肽(L-4F)对apoE-/-Fas-/-C57BL/6狼疮样小鼠自发性狼疮肾病变的影响。方法:选用8~9周龄的雌性小鼠,腹腔注射L-4F,治疗25周。观察肾脏病理改变,测定自身抗体相关细胞因子、脂联素及尿蛋白水平。结果:与apoE-/-Fas-/-C57BL/6小鼠相比,L-4F治疗使apoE-/-Fas-/-C57BL/6小鼠的淋巴结和肾小球的大小均显著减小(P<0.05),并降低血清抗双链DNA抗体、抗氧化磷脂类抗体、IL-6和TNF-α的循环水平,同时提高小鼠血清脂联素水平(P<0.05)。结论:L-4F能显著改善狼疮样小鼠的肾脏病变,对治疗狼疮肾具有一定的临床应用价值。 AIM: To investigate the effects of apolipoprotein A-I mimetic peptide L-4F on the process of ne- phropathia in apoE -/-Fas -/-C57BL/6 lupus mice. METHODS: The apoE -/-Fas -/-C57BL/6 lupus mice (8 -9 weeks old, female) were treated with L-4F by peritoneal injection for 25 weeks. RESULTS: Compared with the vehicle controls, the mice treated with L-4F presented smaller lymph nodes and glomerular tufts (P 〈 0.05), lower serum levels of IgG anti- bodies to double-stranded DNA (P 〈0.05) and oxidized phospholipids, as well as lower levels of inflammatory factors in- cluding IL-6 and TNF-a (P 〈 0.05). Furthermore, serum adiponectin level in apoE-/- Fas -/- C57BL/6 mice was signifi- cantly increased after L-4F treatment for 25 weeks. CONCLUSION : L-4F treatment significantly attenuates the develop- ment of lupus nephritis in apoE-/- Fas-/-C57BIZ6 lupus mice, indicating a potential clinical value of L-4F in the treat- ment of lupus nephritis.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第2期214-218,共5页 Chinese Journal of Pathophysiology
基金 温州市科技计划项目(No.H20100026)
关键词 载脂蛋白A-I模拟肽 狼疮肾炎 模型 小鼠 Apolipoprotein A1 mimetic peptide Lupus nephritis Models, mice
  • 相关文献

参考文献16

  • 1梁柳琴,陈伟玲,邱茜,詹钟平,叶玉津,杨岫岩,许韩师.ROCK对系统性红斑狼疮患者外周血T细胞黏附和迁移的调控[J].中国病理生理杂志,2012,28(12):2270-2273. 被引量:4
  • 2Plump AS,Scott CJ,Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse[J].Proceedings of the National Academy of Sciences(USA),1994,(20):9607-9611.
  • 3Navab M,Berliner JA,Subbanagounder G. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2001,(04):481-488.
  • 4Navab M,Anantharamaiah GM,Reddy ST. Apolipoprotein A-I mimetic peptides[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2005,(07):1325-1331.
  • 5Navab M,Ruchala P,Waring AJ. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids[J].Journal of Lipid Research,2009,(08):1538-1547.
  • 6Feng X,Li H,Rumbin AA. ApoE-/-Fas-/-C57BL/6 mice:a novel murine model simultaneously exhibits lupus nephritis,atherosclerosis,and osteopenia[J].Journal of Lipid Research,2007,(04):794-805.
  • 7Pineau CA,Urowitz MB,Fortin PJ. Osteoporosis in systemic lupus erythematosus:factors associated with referral for bone mineral density studies,prevalence of osteoporosis and factors associated with reduced bone density[J].Lupus,2004,(06):436-441.
  • 8Woo JM,Lin Z,Navab M. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis[J].Arthritis Research &#x0026; Therapy,2010,(03):R93.
  • 9Stanic AK,Stein CM,Morgan AC. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus[J].Proceedings of the National Academy of Sciences(USA),2006,(18):7018-7023.
  • 10Urowitz MB,Bookman AA,Koehler BE. The bimodal mortality pattern of systemic lupus erythematosus[J].American Journal of Medicine,1976,(02):221-225.

二级参考文献10

  • 1Horowitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells and immune regulation [ M]//Wallanee DJ, Hahn BH. Dubois' lupus erythematosus. 6th edition. Philadelphia: Lippincott, Williams & Wilkins, 2002 : 157 - 185.
  • 2Burridge K, Wennerberg K. Rho and Rae take center stage[J]. Cell, 2004, 116(2) :167 -179.
  • 3Street CA, Bryan BA. Rho kinase proteins: pleiotropic modulators of cell survival and apoptosis [ J ]. Anticancer Res, 2011,31 ( 11 ) :3645 - 3657.
  • 4Estess P, DeGrendele HC, Pascual V, et al. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity [ J ]. J Clin Invest, 1998, 102(6) : 1173 - 1182.
  • 5Li Y, Harada T, Juang YT, et al. Phosphorylated ERM is responsible for increased T cell polarization, adhesion and migration in patients with systemic lupus erythematosus [J]. J Immunol, 2007, 178(3) :1938 - 1947.
  • 6Delprato A. Topological and functional properties of the small GTPases protein interaction network[ J]. PLoS One, 2012,7(9) : e44882.
  • 7Honing H, van den Berg TK, van der Pol SM, et al. RhoA activation promotes transendothelial migration of monocytes via ROCK[J]. J Leukoc Biol, 2004, 75(3) : 523 - 528.
  • 8Worthylake RA, Burridge K. RhoA and ROCK promotes migration by limiting membrane protrusions [ J ]. J Biol Chem, 2003, 278 (15) : 13578 - 13584.
  • 9Noma K, Rikitake Y, Oyama N, et al. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury[J]. J Clin Invest, 2008, 118(5) : 1632 - 1644.
  • 10梁柳琴,许韩师,叶玉津,詹钟平,杨岫岩.白细胞介素-15在狼疮性肾炎活动病变中的临床意义[J].中国病理生理杂志,2008,24(8):1581-1584. 被引量:6

共引文献3

同被引文献11

  • 1陶金辉,李向培,厉小梅,阚明,翟志敏,王玮.趋化因子及其受体表达与系统性红斑狼疮临床特征相关性研究[J].中华医学杂志,2006,86(43):3051-3054. 被引量:6
  • 2CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome [ J ]. Thrombosis and haemostasis, 2011,105(6) :1112-1114.
  • 3Hahn BH. Systemic lupus erythematosus and accelerated atherosclersis [ J ]. N Engl J Med,2003,349 ( 25 ) : 2379 -2380.
  • 4Zhang L, Ran L, Garcia GE et al. Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration[ J]. Am J Patho1,2009,175:2518- 2527.
  • 5Feng X, Li H, Rumbin AA, et al. apoE-/-Fas-/- mice: a novel murine model simultaneously exhibits lupus neph ritis , atherosclerosis, and osteopenia [ J ]. J Lipid Res, 2007,48 (40) 794 -805.
  • 6Zhuofeng Lin, Michelle H Kim, Geniffer G, et al. L-4F treASment amelioAStes autoimmune diseASe ASsociASed with lupus-like symptom in apoE-/-Fas-/- mice [ J ]. Journal of Immunology, 2009 ( submitting ).
  • 7Navah M, Anantharamaiah GM, Reddy ST, et al. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoptotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mlce[J]. Circulation,2004,109(25) :3215-3220.
  • 8Mofidi R, Crotty TB, McCarthy P, et al. Assiciation between plaque instability, angiogenesis and systemic lupus erythematosus [ J]. Br J Sur,2007 ,88 :945-950.
  • 9吴帆,龚琦,俞佳文,卢婷婷,李校堃,林灼锋.痛风患者CXCL16血清水平的变化及临床意义[J].中国病理生理杂志,2011,27(10):1977-1981. 被引量:4
  • 10庄宇,简怡娜,谭志明.趋化因子CXCL16与系统性红斑狼疮的研究进展[J].中外医学研究,2012,10(6):146-148. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部